Zyversa Therapeutics Eulerpool News

Zyversa Therapeutics Aktie News

Zyversa Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Zyversa Therapeutics News stellen wir hier zusammen.

• 20. November ·

  Yahoo
  ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial
• 15. November ·

  Yahoo
  Life Sciences Investor Forum: Presentations Now Available for Online Viewing
• 14. November ·

  Yahoo
  ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update
• 12. November ·

  Yahoo
  Life Sciences Investor Forum Agenda Announced for November 14th
• 3. November ·

  Seeking Alpha
  Warning: ZVSA is at high risk of performing badly
• 1. November ·

  Seeking Alpha
  Warning: ZVSA is at high risk of performing badly
• 31. Oktober ·

  Seeking Alpha
  Warning: ZVSA is at high risk of performing badly
• 30. Oktober ·

  TipRanks
  ZyVersa Therapeutics’ Shareholder Approvals and Director Elections
• 29. Oktober ·

  Yahoo
  ZyVersa Therapeutics Highlights Review Article Supporting the Need for Drug Therapies to Treat the Inflammation of Obesity in Addition to Weight Loss Drugs
• 29. Oktober ·

  TipRanks
  ZyVersa highlights review article on inflammasome-induced inflammation